About this item:

179 Views | 199 Downloads

Author Notes:

Corresponding Author: Colin Derdeyn, MD, 510 South Kingshighway Blvd., St Louis, MO 63110, Tel: 314 362-3225; Fax 314 362-2530, derdeync@wustl.edu

See publication for full list of disclosures.

Subject:

Research Funding:

The SAMMPRIS trial was funded by a research grant (U01 NS058728) from the US Public Health Service National Institute of Neurological Disorders and Stroke (NINDS).

In addition, the following Clinical and Translational Science Awards, funded by the National Institutes of Health, provided local support for the evaluation of patients in the trial: Medical University of South Carolina (UL1RR029882), University of Florida (UL1RR029889), University of Cincinnati (UL1RR029890), and University of California, San Francisco (UL1RR024131).

Stryker Neurovascular (formerly Boston Scientific Neurovascular) provided study devices and supplemental funding for third party device distribution, site monitoring and study auditing.

This research is also supported by the Investigator-Sponsored Study Program of AstraZeneca that donates rosuvastatin (Crestor) to study patients.

Keywords:

  • Aged
  • Angioplasty
  • Brain Ischemia
  • Cerebral Hemorrhage
  • Female
  • Humans
  • Incidence
  • Intracranial Arteriosclerosis
  • Male
  • Middle Aged
  • Postoperative Complications
  • Risk Assessment
  • Stents
  • Stroke
  • Survival Analysis
  • Survival Rate
  • Treatment Outcome
  • United States

Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial

Tools:

Journal Title:

Neurosurgery

Volume:

Volume 72, Number 5

Publisher:

, Pages 777-795

Type of Work:

Article | Post-print: After Peer Review

Abstract:

BACKGROUND:: Enrollment in the Stenting and Aggressive Medical Management for the Prevention of stroke in Intracranial Stenosis (SAMMPRIS) trial was halted owing to higher-than-expected 30-day stroke rates in the stenting arm. Improvement in periprocedural stroke rates from angioplasty and stenting for intracranial atherosclerotic disease (ICAD) requires an understanding of the mechanisms of these events. OBJECTIVE:: To identify the types and mechanisms of periprocedural stroke after angioplasty and stenting for ICAD. METHODS:: Patients who experienced a hemorrhagic or ischemic stroke or a cerebral infarct with temporary signs within 30 days of attempted angioplasty and stenting in SAMMPRIS were identified. Study records, including case report forms, procedure notes, and imaging were reviewed. Strokes were categorized as ischemic or hemorrhagic. Ischemic strokes were categorized as perforator territory, distal embolic, or delayed stent thrombosis. Hemorrhagic strokes were categorized as subarachnoid or intraparenchymal. Causes of hemorrhage (wire perforation, vessel rupture) were recorded. RESULTS:: Three patients had an ischemic stroke after diagnostic angiography. Two of these strokes were unrelated to the procedure. Twenty-one patients had an ischemic stroke (n = 19) or cerebral infarct with temporary signs (n = 2) within 30 days of angioplasty and stenting. Most (n = 15) were perforator territory and many of these occurred after angiographically successful angioplasty and stenting of the basilar artery (n = 8). Six patients experienced a subarachnoid hemorrhage (3 from wire perforation) and 7 had a delayed intraparenchymal hemorrhage. CONCLUSION:: Efforts at reducing complications from angioplasty and stenting for ICAD must focus on reducing the risks of regional perforator infarction, delayed intraparenchymal hemorrhage, and wire perforation. ABBREVIATIONS:: ACT, activated clotting timeCITS, cerebral infarction with temporary signsICAD, intracranial atherosclerotic diseaseIPH, intraparenchymal hemorrhagemRS, modified Rankin ScorePTAS, percutaneous transluminal angioplastySAH, subarachnoid hemorrhageSAMMPRIS, Stenting and Aggressive Medical Management for the Prevention of Recurrent stroke in Intracranial StenosisTIA, transient ischemic attack.

Copyright information:

© 2013 by the Congress of Neurological Surgeons.

Export to EndNote